Rapid Nutrition PLC is pleased to announce the official commencement of production for its highly anticipated product, Azurene Immunity Booster...
Rapid Nutrition and the investor (“ASO”) have mutually agreed to terminate the utilization of the second tranche of the amortized convertible loan facility...
Rapid Nutrition announces its interim results for the first half of 2023, showcasing a robust financial and strategic performance that aligns perfectly with its outlined strategic roadmap.
Rapid Nutrition is excited to announce that it is right on track for the highly-anticipated launch of Azurene Immunity Booster in the fourth quarter of this year. As the world prepares for the upcoming winter season, which can be especially challenging for travellers, or those who work in confined spaces.
Rapid Nutrition shares its significant accomplishments and notable milestones for the first half of 2023, aligning seamlessly with the strategic roadmap delineated earlier in the year.
Rapid Nutrition announce their up and coming launch of its innovative service, offering personalised vitamin packs customised to meet the unique health needs and goals of its customers...
Rapid Nutrition is pleased to announce the initiation of production for its highly anticipated Azurene Immunity formula. As Europe braces for the forthcoming winter season..
Rapid Nutrition is pleased to present a comprehensive presentation that delves into the intricacies of our foray into the Chinese consumer market. This presentation aims to offer valuable insights, intricate details, and a strategic outlook on how we intend to navigate this promising venture.
China’s Strong Demand for Natural Products Spells Opportunity for International Brands. With a deep understanding of the market, Rapid Nutrition aims to establish itself as a trusted brand by offering innovative and high-quality nutritional products that cater to the evolving demands of Chinese consumers, further bolstering investor confidence.
Rapid Nutrition is delighted to announce significant progress in advancing the production and distribution of its flagship weight loss brand SystemLS, and its patented herbal immunity formula Azurene, with a strong focus on entering the flourishing Asia Pacific market.
Rapid Nutrition held its Annual General Meeting on 21 June 2023 at 10:00 pm (British Summer Time) / 7:00 am (Australian Eastern Standard Time) on 22 June 2023.
A leading player in the small- and mid-cap market, In Extenso Finance is recognized for its M&A and its advisory for listed company considering its listing sponsor status
Rapid Nutrition continues to evolve its signature line to capitalise on global market trends, firming up the foundation for success in its quality weight-loss line by delivering on customer expectations...
Annual General Meeting of the Company at 2/40-46 Nestor Drive, Meadowbrook, 4131 QLD, Australia on 21 June 2023 at 10:00 pm (British Summer Time) / 7:00 am (Australian Eastern Standard Time) on 22 June 2023.
Rapid Nutrition recently completed a financing commitment of up to EUR 3 million with Atlas Special Opportunities. The new investment will support potential acquisition activity for Rapid Nutrition. London-based investment fund Atlas Capital Markets ...
Rapid Nutrition shared an update on its 2023 roadmap and outlook. Key updates for the company include...
Rapid Nutrition release fiscal year 2022 results...
Final redemption of the remaining EUR 192,000 Convertible Bonds (on 25th April, 2023) has now been completed with no more convertibles bonds outstanding. This formally completes the termination of the Negma Agreement
Rapid Nutrition announces today that it has terminated the Investment Agreement with the Negma Group...
Rapid Nutrition outlines its growth strategy for the year ahead as well as key company updates...
With reference to the company’s recent acquisition of The Plant-Based Bundle announced on the 30th May 2022 Rapid Nutrition has successfully completed the second and final milestone payment
Rapid Nutrition announces that a general meeting (the “General Meeting”) has been held at 7.00am AEST (Australian Eastern Standard Time) on 9 December 2022. All resolutions as set out in the notice dated 21 November 2022 and put to the General Meeting were passed
Rapid Nutrition announces that it has entered into a non-binding letter of intent with FFS Beauty Limited (FFS), one of Europe’s leading female-focused shaving and beauty subscription businesses. The acquisition is anticipated to close later this year, subject to required terms and approvals.
Rapid Nutrition has entered into discussions to acquire a successful beauty business...
Notice of General Meeting (“GM”) of the Company which we are holding at 40-46 Nestor Drive, Meadowbrook, 4131 QLD, Australia on Friday 9 December 2022 at 7am (AEST), 9pm UK Time, 8 December 2022...
Long-time film and TV professional Jeff Reingold, who shares a dual passion for health and wellness, has joined the Rapid Nutrition (Euronext Growth: ALRPD) board as a non-executive director.
Corrigendum: With reference to the Rapid Nutrition PLC (Euronext Growth: ALRPD) recent earnings results published on the on the 5th of October 2022, the Gross Profit was misstated showing $112,820 when should have shown $1,879,603.
With reference to the company’s recent trading update on the 6th of September 2022, Rapid Nutrition PLC (Euronext Growth: ALRPD, OTCQB: RPNRF), today published its H1 2022 half-year results available on the company website.
Rapid Nutrition releases a trading update ahead of publishing its interim accounts
Rapid Nutrition is partnering with leading Australian manufacturer Tismore to commence the first production run of its patented immunity support formula. The natural immunity support formula Azurene is an anti-inflammatory formula that may aid in relieving cold and flu symptoms and also supports circulation and eye health.
Subscribe for Updates